Rita Belobrov
Nurse Practitioner · Morristown, NJNPI 1588006209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 32.8% of the total. 2025 is the largest year on record at $2,971, 6.4 times the $467 reported in 2021. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$475
- Pfizer$364
- Aimmune Therapeutics, Inc.$294
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$273
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,63497%
- Education$1983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 102 | $2,244 |
| Johnson & Johnson | 24 | $1,003 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $475 |
| Pfizer | 21 | $364 |
| Aimmune Therapeutics, Inc. | 12 | $294 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $273 |
| Madrigal Pharmaceuticals | 12 | $192 |
| Boston Scientific | 10 | $192 |
| QOL Medical, LLC | 11 | $183 |
| Phathom Pharmaceuticals, Inc. | 4 | $170 |
| Ardelyx, Inc. | 8 | $163 |
| Regeneron Healthcare Solutions, Inc. | 7 | $128 |
| Olympus America Inc. | 2 | $128 |
| Ferring Pharmaceuticals Inc. | 6 | $124 |
| Kowa Pharmaceuticals America, Inc. | 1 | $102 |
| Braintree Laboratories, Inc. | 4 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| Lilly USA, LLC | 5 | $91 |
| Evoke Pharma, Inc. | 5 | $77 |
| Gilead | 4 | $71 |
| Vivus LLC | 4 | $62 |
| Celltrion USA Inc. | 3 | $51 |
| Nestle Healthcare Nutrition Inc. | 3 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Exact Sciences | 1 | $32 |
| Bayer | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Organon | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,832 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 31 | $16,396 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 36 | $6,323 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 17 | $2,780 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 14 | $907 |
| Omeprazole | 35 | $700 |
| Dicyclomine Hcl | 16 | $499 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 29 | $403 |
| Pantoprazole Sodium | 27 | $220 |
| Esomeprazole Magnesium | 11 | $164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $2,244 | $16,39631 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $124 | $6,32336 claims |
| Braintree Laboratories, Inc.Sutab | $101 | $2,78017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Morristown
- Nancy BonnetMorristown$407K
- Tina OcchiutoMorristown$25K
- Tana LaplacaMorristown$11K
- Lillian ImperanteMorristown$10K
- Mary BakerMorristown$9K
- Elizabeth LangloisMorristown$7K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.